Get started
Author

Paul C.M.S. Verhagen

Observed names: P C M S Verhagen, P Verhagen, P. C. M. S. Verhagen, P. C.M.S. Verhagen, P. Verhagen, P.C.M.S. Verhagen, PAUL C. M. S. VERHAGEN, PCMS Verhagen, Paul C M S Verhagen, Paul C Verhagen, Paul C. M. S. Verhagen, Paul C. Verhagen, Paul C.M.S Verhagen, Paul Cms Verhagen, Paul Verhagen, Verhagen P., Verhagen, Paul
Observed institutions: Utrecht University, Universität Ulm, Erasmus MC, University Medical Center Utrecht, OLVG, Erasmus MC Cancer Institute, University Hospital Ulm, Academisch Ziekenhuis Rotterdam, Erasmus University Rotterdam
ORCID: 0000-0003-2565-6682
Observed ORCID: 0000-0003-2565-6682
OpenAlex ID: A5000223767
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)
2012 · Michel Bolla, Hein van Poppel, et al. · The Lancet · 867
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
2018 · Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, et al. · European Urology · 571
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis
2019 · Sarah Burdett, Liselotte M. Boevé, et al. · European Urology · 327
PDF
Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review
2017 · Ivo G. Schoots, Keren Zaccai, et al. · The Journal of Urology · 207
Prostate cancer: ESMO Consensus Conference Guidelines 2012
2013 · A. Horwich, J. Hugosson, et al. · Annals of Oncology · 145
The PTEN gene in locally progressive prostate cancer is preferentially inactivated by bi‐allelic gene deletion
2006 · PCMS Verhagen, PW van Duijn, et al. · The Journal of Pathology · 104
Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
2009 · Karin G. Hermans, Joost L. Boormans, et al. · Clinical Cancer Research · 89
PDF
Kidney and Urinary Tract Imaging: Triple-Bolus Multidetector CT Urography as a One-Stop Shop—Protocol Design, Opacification, and Image Quality Analysis
2010 · Maka Kekelidze, Roy S. Dwarkasing, et al. · Radiology · 84
Does Local Treatment of the Prostate in Advanced and/or Lymph Node Metastatic Disease Improve Efficacy of Androgen-Deprivation Therapy? A Systematic Review
2010 · Paul C.M.S. Verhagen, Fritz H. Schröder, et al. · European Urology · 79
Histopathological characteristics of lymph node metastases predict cancer‐specific survival in node‐positive prostate cancer
2008 · Joost L. Boormans, Mark F. Wildhagen, et al. · British Journal of Urology · 49
Percutaneous nephrolithotomy for treating renal calculi in children
2005 · Joost L. Boormans, Jeroen R. Scheepe, et al. · British Journal of Urology · 48
Current Vaccination Strategies for Prostate Cancer
2011 · Steven Joniau, Per-Anders Abrahamsson, et al. · European Urology · 45
Short report: Eosinophilic cystitis
2001 · P C M S Verhagen · Archives of Disease in Childhood · 45
PDF
E17K substitution in AKT1 in prostate cancer
2010 · J L Boormans, H Korsten, et al. · British Journal of Cancer · 40
PDF
Expression of the Androgen-Regulated Fusion Gene TMPRSS2-ERG Does Not Predict Response to Endocrine Treatment in Hormone-Naïve, Node-Positive Prostate Cancer
2009 · Joost L. Boormans, Karin G. Hermans, et al. · European Urology · 40
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
2024 · Susan Halabi, Akash Roy, et al. · Journal of Clinical Oncology · 36
PDF
Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial
2020 · Liselotte Boevé, Maarten C.C.M. Hulshof, et al. · European Urology · 34
Surgical Anatomy of the 10th and 11th Intercostal, and Subcostal Nerves: Prevention of Damage During Lumbotomy
2011 · Teunette van der Graaf, Paul C.M.S. Verhagen, et al. · The Journal of Urology · 34
When to start cytotoxic therapy in asymptomatic patients with hormone refractory prostate cancer?
2008 · P. Hamberg, P.C.M.S. Verhagen, et al. · European Journal of Cancer · 31
Diagnostic Value of Urinary Dysmorphic Erythrocytes in Clinical Practice
2010 · Meindert J. Crop, Yolanda B. de Rijke, et al. · Nephron Clinical Practice · 30
PDF
Biomarker-Oriented Therapy in Bladder and Renal Cancer
2021 · Mathijs P. Scholtes, Arnout R. Alberts, et al. · International Journal of Molecular Sciences · 29
PDF
Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers
2000 · Paul C.M.S Verhagen, Xiao Lin Zhu, et al. · Cancer Genetics and Cytogenetics · 29
Deletion of chromosomal region 6q14‐16 in prostate cancer
2002 · Paul C.M.S. Verhagen, Karin G.L. Hermans, et al. · International Journal of Cancer · 28
PDF
Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: results of a randomized trial
2013 · Paul C. M. S. Verhagen, Mark F. Wildhagen, et al. · World Journal of Urology · 25
Prognostic Factors in Localised Prostate Cancer with Emphasis on the Application of Molecular Techniques
2002 · P Verhagen · European Urology · 22
Works count: 91
Citation count: 3,314
H-index: 24
I10-index: 38
Year
Topic
Type